All In Biotech

Drug Trial Radar · NCT00899379

Treatment of Multiple Attacks of Acute Migraine (0462-025)

A Randomized, Triple-Blind, Placebo-Controlled, Outpatient Study to Examine the Safety and Efficacy of MK462 10 mg p.o. in the Treatment of Multiple Attacks of Migraine Headache

Last checked: Nov 19, 2026Latest source record: Feb 3, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 473 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

473

Actual

Start

Apr 1995

Primary completion

Jan 1996

Study completion Apr 1996

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
May 12, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A study to evaluate rizatriptan for the treatment of multiple attacks of acute migraine compared to placebo.

Conditions

  • Migraine Headache

Interventions

  • rizatriptan benzoateDrug

    Rizatriptan 10 mg p.o. at onset of moderate to severe migraine headache

  • Comparator: PlaceboDrug

    Placebo to Rizatriptan, Oral Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain Relief at 2 Hours During the First Migraine Attack PeriodTime frame: 2 hours

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.